Digestive Cancer Clinical Trial
— IMPROVEDOfficial title:
Implementation of coMplex PeRi-OperatiVe intervEntion in olDer Patients With Cancer : a Multicenter Randomized Controlled Trial
Incidence of digestive cancers increase and half of new cases will be people of 75 years or more in 2050. Surgery is one of the main treatment's strategy but post-operative morbi-mortality increases with age. Pre-operative Geriatric Assessment enable to identify frail or vulnerable patients at risk of post-operative complications. The coordinating team postulate that a geriatric and surgical co-management with a combination of several targeted geriatric interventions with usual post-operative care could improve the post-operative care and decrease the risk of morbi-mortality in older patients with digestive cancers.
Status | Not yet recruiting |
Enrollment | 630 |
Est. completion date | October 14, 2024 |
Est. primary completion date | August 14, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 75 Years and older |
Eligibility | Inclusion Criteria: - Aged 75 years or more - Gastric, colo-rectal, pancreatic cancer or hepatic metastasis needed a surgical treatment - Health Insurance - At risk of post-operative complication through Surgical Risk Calculator (>25%) or surgeon judgment. - Written consent Exclusion Criteria: - Surgery in emergency |
Country | Name | City | State |
---|---|---|---|
France | Assistance Publique Hôpitaux de Paris - Hôpital européen Georges-Pompidou | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | Federation of Research in Surgery (FRENCH), PACAN - Plateforme de Recherche Clinique Patients Agés et Cancer, Société Francophone d'Onco-Gériatrie |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of patients with postoperative complications of grade II or higher in the Clavien-Dindo | at 30 days after surgery | ||
Secondary | Percentage of patients with postoperative complications of each grade in the Clavien-Dindo | at Day 14 and Day 30 | ||
Secondary | Percentage of patients with each complication among a prespecified list of complication | at Day 14 and Day 30 | ||
Secondary | Social Status | at Day 14 and Day 30 after surgery | ||
Secondary | Activities of Daily Living Scale | at Day 14 and Day 30 after surgery | ||
Secondary | Instrumental Activities of Daily Living Scale | at Day 14 and Day 30 after surgery | ||
Secondary | Mini-Geriatric Depressive Scale | at Day 14 and Day 30 after surgery | ||
Secondary | Mini cognitive scale | at Day 14 and Day 30 after surgery | ||
Secondary | Updated Charlson Comorbidity Index | at Day 14 and Day 30 after surgery | ||
Secondary | Mini Nutritional Assessment-Short Form | at Day 14 and Day 30 after surgery | ||
Secondary | Body mass index | at Day 14 and Day 30 after surgery | ||
Secondary | Timed Up and Go | at Day 14 and Day 30 after surgery | ||
Secondary | Gait speed | at Day 14 and Day 30 after surgery | ||
Secondary | Percentage of patients with cancelled surgeries | at Day 0 to Day 8 | ||
Secondary | Percentage of patients with postponed surgeries | at Day 0 to Day 8 | ||
Secondary | Percentage of patients with complete intervention in the experimental arm | at Day 0 to Day 8 | ||
Secondary | Time of onset of each post-operative complication | at Day 14, Day 30 and Day 90 after surgery | ||
Secondary | Percentage of patients transfered to geriatric unit, intensive care unit, rehabilitation unit or other departement. | at Day 14, Day 30 and Day 90 after surgery | ||
Secondary | Length of stay to geriatric unit, intensive care unit, rehabilitation unit or other departement. | at Day 14, Day 30 and Day 90 after surgery | ||
Secondary | Quality of life (European Organisation for Research and Treatment of Cancer - Quality of life - C30) | at Day 30 and Day 90 after surgery | ||
Secondary | Quality of life (European Organisation for Research and Treatment of Cancer - Quality of life - ELD14) | at Day 30 and Day 90 after surgery | ||
Secondary | Overall survival | at Day 30 and Day 90 after surgery | ||
Secondary | Length of hospitalizations | at Day 14 after surgery | ||
Secondary | Percentage of patients returned at home or institutionalization | at Day 14, Day 30 and Day 90 after surgery | ||
Secondary | Autonomy (Activities of Daily Living scale) | at Day 14 , Day 30 and Day 90 after surgery | ||
Secondary | Patient and professionals experience (ancillary study using semi-directive interviews) | at Day 30 after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04899492 -
Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery
|
N/A | |
Recruiting |
NCT04584008 -
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
|
N/A | |
Terminated |
NCT04589884 -
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
|
||
Completed |
NCT02386397 -
Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT05121038 -
CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab
|
Phase 1/Phase 2 | |
Recruiting |
NCT04715581 -
Multicomponent Prehabilitation and Outcomes in Elderly Patients With Frailty
|
N/A | |
Completed |
NCT04008056 -
Impact of Patient Reported Outcomes for Pre-chemotherapy Medical Decision in Day Patients With Digestive Cancer
|
||
Recruiting |
NCT05628857 -
A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
|
Phase 2 | |
Terminated |
NCT03294252 -
Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers
|
Phase 1/Phase 2 | |
Completed |
NCT02169908 -
Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin
|
N/A | |
Completed |
NCT02797197 -
Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy
|
N/A | |
Completed |
NCT04379232 -
Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center
|
||
Recruiting |
NCT05961111 -
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
|
Early Phase 1 | |
Recruiting |
NCT03449264 -
Development of Clinical and Biological Database
|
N/A | |
Recruiting |
NCT04268121 -
Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas
|
Phase 2 | |
Recruiting |
NCT03670199 -
Improving the Quality of Life of Cancer Patients Through a Perioperative and Coordinated Nutrition and Physical Care Program.
|
N/A | |
Withdrawn |
NCT01763489 -
ASSIST Tool and Surgical Randomized Controlled Trial Applicability
|
N/A | |
Completed |
NCT02894775 -
Factors Influencing Inclusion in Digestive Cancer Clinical Trials
|
N/A | |
Recruiting |
NCT04530890 -
Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer
|
N/A | |
Recruiting |
NCT05867966 -
Psychoneurological Symptom Cluster in Oncology
|
N/A |